Manolete Partners Share Discussion Threads

[jonwig] 26/1/2021 16:34

74tom - "I'm not much of a fan of a company that relies on the failure of others to succeed".

Nor I. Honest insolvency is no crime, but thre are criminals who exploit the laws for their own gain, and to evade taxes. A company which pursues these in partnership with HMRC is hardly being unethical.

[primarch1] 26/1/2021 16:33

Longterm great buying opportunity because let's face it sad as it is for the people losing their business Covid has wreaked havoc I can possibly see a cap raise to improve cash flow but can only see the business thriving in the next few years we're also some decent positive to take from the update.still painfull to take that hit joys of aim

[cockerhoop] 26/1/2021 16:31

jonwig,

Agree it's ironic how it's played out, I'd suspected a raise would be on the cards due to tardy cash collection rather than a profit warning.

I suppose when the accounting is that aggressive in that a large proportion of your profits is unrealised gains on newly written cases when the cases temporarily dry up it causes issues much more quickly than if using conservative fair value assumptions.

[dr biotech] 26/1/2021 16:08

Just hoping for a dead cat bounce. This may become interesting later this year but don’t see a short term recovery.

It’s also another IPO that’s struggled in its infancy. Oddly enough biggest bear case here was the accounting rather than the volume of business. This just adds to the doubts.

[bogman1] 26/1/2021 15:53

Added sub 200. Definite buy at this price. 1-2 years from now? Come on. There is going to be an avalanche of insolvency

[spooky] 26/1/2021 15:49

'Think I’ll sell out tomorrow.' You have to laugh when you see someone posting that on a collapsing share.

[primarch1] 26/1/2021 15:46

All ongoing case costs covered massive overreaction

[elliotset] 26/1/2021 15:41

The line that kills it As a consequence of the above factors, the Board expects realised profits tobe above, but unrealised profits to be significantly below, marketexpectations and therefore for the Company to be overall marginally EBITprofitable in H2.

[dr biotech] 26/1/2021 15:27

Two SCSW tips taking an absolute pummelling today with this and Heiq also down about 20%.

I don’t have a big position here, but it’s still a moderately painful hit. Think I’ll sell out tomorrow.

[kaos3] 26/1/2021 15:22

there was no hint from the Co. not good. and once it starts ....

hence the reaction imho
plus the general markets

[bogman1] 26/1/2021 15:18

Trading update did not seem this bad. Seems to be a massive overreaction IMO.

[dr biotech] 26/1/2021 15:02

Not a great update. Wonder why they released it mid afternoon too.

[nw99] 20/1/2021 15:06

Seller cleared

[xpertgreeny] 20/1/2021 13:31

Hi Tole - yes fully agree. Good solid stream of buys today as well I see.

[tole] 19/1/2021 16:04

Yes big trade looks to have cleared some stock and price ticking up with it

[xpertgreeny] 19/1/2021 15:31

Anyone else notice a buy order go through for 505k shares today at 269p?

[maddox] 12/1/2021 12:49

There is already competition in this market its not a monopoly situation - however, it's mostly in the larger no-win/no-fee area (75%) of the market; not the funded litigation portion where MANO are well established.

It is this sub-sector of the market that is still developing and growing so there is plenty of headroom and runway for future growth. The consequence of this is that there is space for competitors to join this market and the competitive environment will remain benign. I don't thus think that MANO will be cutting its margins anytime soon.

[bogman1] 12/1/2021 12:40

In a good business there will always be the danger of competition this market and company are in their infancy and at the forefront of the market. I will buy into the competition if and when they arise

[kaos3] 12/1/2021 10:11

imho - competitors will come in and most of them will fail as they mostly do. meanwhile margins will be much lower. in the long run quality, capital, relationships, experience will prevail, margins will rise again

[fredfishcake] 12/1/2021 09:59

Excellent session. I think my main worry would be that some of the existing staff decide to split off into another company and do the same thing with lower margins. They'd have to get a source of finance to start, and wouldn't get any returns for a while. On balance, as long as they're well paid at MANO I don't see any pressing reason why any of them would do this. I think it's a valid concern that large margins attract competition, but for the moment they can make hay.

[scubadiverr] 11/1/2021 21:58

Correction 53% went with buy